Daxor Co. (NASDAQ:DXR) Short Interest Down 13.6% in March

Daxor Co. (NASDAQ:DXR) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 7,000 shares, a drop of 13.6% from the March 15th total of 8,100 shares. Currently, 0.4% of the company’s stock are short sold. Based on an average daily volume of 2,700 shares, the short-interest ratio is presently 2.6 days.

Daxor Stock Performance

Shares of DXR stock traded up $0.05 on Tuesday, reaching $9.55. 577 shares of the stock were exchanged, compared to its average volume of 3,441. Daxor has a twelve month low of $7.11 and a twelve month high of $13.13. The business’s 50 day moving average price is $8.54 and its 200 day moving average price is $8.57.

Daxor Company Profile

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.